Ideas to Action:

Independent research for global prosperity

Global Health Policy

CGD experts discuss such issues as health financing, drug resistance, clinical trials, vaccine development, HIV/AIDS, and health-related foreign assistance.

X

Global Health Policy

Feed

 

The Aid Fungibility Debate and Medical Journal Peer Review

The Lancet just published a letter I wrote questioning an influential study in its pages that concluded that most or all foreign aid for health goes into non-health uses. The letter follows up on concerns I expressed in this space in April 2010. Why the 2.5-year lag? Only this past January did the Seattle-based Institute for Health Metrics and Evaluation (IHME) share the data set and computer code that it used to generate the published findings. And only with those in hand could I check my concerns and describe them to others with credibility. (I'm grateful to the kind people at IHME who gave me the data and code, but don't want to let the institution per se off the hook.)

Confusingly, in May the Public Library of Science published another critique of the same article. I questioned that reanalysis, and it was eventually retracted.

Here, I sketch my argument, comment on the reply from Chunling Lu and Christopher Murray, then call out the Lancet for a certain lack of transparency, as well as for sometimes bringing more reputation than rigor to policy-relevant social science research.

Health Insurer to the Poor?

Awhile back, Christine Bowers over at the PSD blog commented on a trend in Mexico towards micro-insurance, noting that 2007 may be the Year of Micro-Insurance:

I think this could be the year that we wake up to the possibilities of microinsurance. Not only life insurance, but also health, crop, livestock and other insurance policies are a classic win-win for the poor and the companies who serve them. Microinsurance is every bit as powerful as microcredit.